Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 567

1.

Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.

Keck PE, Orsulak PJ, Cutler AJ, Sanchez R, Torbeyns A, Marcus RN, McQuade RD, Carson WH; CN138-135 Study Group.

J Affect Disord. 2009 Jan;112(1-3):36-49. doi: 10.1016/j.jad.2008.05.014. Epub 2008 Oct 2.

PMID:
18835043
2.

Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.

Vieta E, Owen R, Baudelet C, McQuade RD, Sanchez R, Marcus RN.

Curr Med Res Opin. 2010 Jun;26(6):1485-96. doi: 10.1185/03007991003779380.

PMID:
20429835
3.

A 40-week double-blind aripiprazole versus lithium follow-up of a 12-week acute phase study (total 52 weeks) in bipolar I disorder.

El-Mallakh RS, Marcus R, Baudelet C, McQuade R, Carson WH, Owen R.

J Affect Disord. 2012 Feb;136(3):258-66. doi: 10.1016/j.jad.2011.11.043. Epub 2011 Dec 30.

PMID:
22209190
4.

Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.

Findling RL, Nyilas M, Forbes RA, McQuade RD, Jin N, Iwamoto T, Ivanova S, Carson WH, Chang K.

J Clin Psychiatry. 2009 Oct;70(10):1441-51. doi: 10.4088/JCP.09m05164yel.

PMID:
19906348
5.

Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Keck PE Jr, Calabrese JR, McIntyre RS, McQuade RD, Carson WH, Eudicone JM, Carlson BX, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2007 Oct;68(10):1480-91.

PMID:
17960961
6.

Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.

Suppes T, Eudicone J, McQuade R, Pikalov A 3rd, Carlson B.

J Affect Disord. 2008 Apr;107(1-3):145-54. Epub 2007 Sep 27.

PMID:
17904226
7.

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.

Sachs G, Sanchez R, Marcus R, Stock E, McQuade R, Carson W, Abou-Gharbia N, Impellizzeri C, Kaplita S, Rollin L, Iwamoto T; Aripiprazole Study Group.

J Psychopharmacol. 2006 Jul;20(4):536-46. Epub 2006 Jan 9.

PMID:
16401666
8.

Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

Vieta E, T'joen C, McQuade RD, Carson WH Jr, Marcus RN, Sanchez R, Owen R, Nameche L.

Am J Psychiatry. 2008 Oct;165(10):1316-25. doi: 10.1176/appi.ajp.2008.07101560. Epub 2008 Apr 1.

PMID:
18381903
9.

A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder.

Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, Vågerö M, Svensson K.

J Clin Psychiatry. 2005 Jan;66(1):111-21.

PMID:
15669897
10.

A randomized, double-blind, placebo-controlled 26-week trial of aripiprazole in recently manic patients with bipolar I disorder.

Keck PE Jr, Calabrese JR, McQuade RD, Carson WH, Carlson BX, Rollin LM, Marcus RN, Sanchez R; Aripiprazole Study Group.

J Clin Psychiatry. 2006 Apr;67(4):626-37.

PMID:
16669728
11.

Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.

Findling RL, Correll CU, Nyilas M, Forbes RA, McQuade RD, Jin N, Ivanova S, Mankoski R, Carson WH, Carlson GA.

Bipolar Disord. 2013 Mar;15(2):138-49. doi: 10.1111/bdi.12042.

PMID:
23437959
12.

Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.

Mankoski R, Zhao J, Carson WH, Mathew SJ, Forbes RA.

J Child Adolesc Psychopharmacol. 2011 Aug;21(4):359-64. doi: 10.1089/cap.2010.0100. Epub 2011 Aug 8.

PMID:
21823911
13.

Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.

McIntyre RS, Konarski JZ, Jones M, Paulsson B.

J Affect Disord. 2007;100 Suppl 1:S5-14. Epub 2007 Mar 27.

PMID:
17391773
14.
15.

Aripiprazole alone or in combination for acute mania.

Brown R, Taylor MJ, Geddes J.

Cochrane Database Syst Rev. 2013 Dec 17;(12):CD005000. doi: 10.1002/14651858.CD005000.pub2. Review.

PMID:
24346956
16.

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial.

Mazza M, Squillacioti MR, Pecora RD, Janiri L, Bria P.

Expert Opin Pharmacother. 2008 Dec;9(18):3145-9. doi: 10.1517/14656560802504490 .

PMID:
19040335
17.

Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.

Thase ME, Jonas A, Khan A, Bowden CL, Wu X, McQuade RD, Carson WH, Marcus RN, Owen R.

J Clin Psychopharmacol. 2008 Feb;28(1):13-20. doi: 10.1097/jcp.0b013e3181618eb4. Erratum in: J Clin Psychopharmacol. 2009 Feb;29(1):38.

PMID:
18204335
18.

Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.

Sussman N, Mullen J, Paulsson B, Vågerö M.

J Affect Disord. 2007;100 Suppl 1:S55-63. Epub 2007 Mar 26.

PMID:
17383736
19.

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole for the treatment of acute manic or mixed episodes in Asian patients with bipolar I disorder (the AMAZE study).

Kanba S, Kawasaki H, Ishigooka J, Sakamoto K, Kinoshita T, Kuroki T.

World J Biol Psychiatry. 2014 Feb;15(2):113-21. doi: 10.3109/15622975.2012.669047. Epub 2012 Apr 30.

PMID:
22540407
20.

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.

Keck PE Jr, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G; Aripiprazole Study Group.

Am J Psychiatry. 2003 Sep;160(9):1651-8.

PMID:
12944341

Supplemental Content

Support Center